Tim H. Brümmendorf

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele et al. · Leukemia · 2017 · 339 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Telomere length in leukocyte subpopulations of patients with aplastic anemia

Tim H. Brümmendorf, Jaroslaw P. Maciejewski, Jennifer Sze Man Mak et al. · Blood · 2001 · 232 citations

Medicine, Hematology, Immunology +13

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

Jörge E. Cortes, D-W Kim, Emmanuel Raffoux et al. · Leukemia · 2008 · 201 citations

Medicine, Pharmacology, Pharmacotherapy +8

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Andrea Kaifie, Martin Kirschner, Dominik Wolf‎ et al. · Journal of Hematology & Oncology · 2016 · 184 citations · Full text

Medicine, Hematology, Internal Medicine +17

Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party

Judith Marsh, Andrea Bacigalupo, Hubert Schrezenmeier et al. · Blood · 2012 · 181 citations

Medicine, Hematology, Pharmacotherapy +4